CSIMarket
 
Adhera Therapeutics Inc   (MRNA)
Other Ticker:  
 
 

Adhera Therapeutics Inc Growth Comparisons

Select each growth Category to receive further Information



MRNA Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 22989.76% 14.68% 11.47% 12.95%
Q / Q Revenue Growth (Q1 MRQ) 239.38% 1.56% -1.59% 0.09%
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 31527.33% 9.44% 8.41% -0.17%
Seq. Revenue Growth (for 12 months ending Q1 TTM) 240.06% 3.53% 3.14% 3.09%
Revenue 5 Year Average Growth 311.61% 14.2% 9.32% 7.85%
Expected Revenue Growth (Y/Y) - 2.5% 1.89% 0.98%


MRNA's Growth Comparisons in I. Quarter 2021




Facing 22989.76% year on year sales decrease in the first quarter 2021, to $ 1.94 billions, Adhera Therapeutics Inc reported smaller declines than the Major Pharmaceutical Preparations industry with 14.68%, and less than 11.47% improvement in the Healthcare sector. Comparing first quarter sales growth, both Major Pharmaceutical Preparations industry and Adhera Therapeutics Inc outperformed 12.95% overall market increase.

Company's sequential Revenue growth rate was impressive 239.38% from the forth quarter. Average yearly sales growth for Adhera Therapeutics Inc is 311.61%, while S & P 500's average annual sales growth is 7.85% over the five years, including only Businesses with the first quarter 2021 financial reports.


Growth Rates of MRNA's Income in the first quarter 2021


MRNA Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - 20.34% 36.82% 87.64%
Seq. Operating Income Change (Q1 MRQ) - - 125.53% 53.57%
Y / Y Operating Income Growth (Q1 TTM) - -38.59% -13.97% -7.05%
Seq. Operating Income Growth (Q1 TTM) - 9% 10.64% 18.14%
Operating Income 5 Year Avg. Change - 9% 2.27% 8.58%


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - 50.29% 50.67% 147.04%
Seq. Income from Cont. Ops. Change (Q1 MRQ) - - 351.39% 58.7%
Y / Y Income from Cont. Ops. Change (Q1 TTM) - -31.65% -25.16% -0.73%
Seq. Income from Cont. Ops. Change (Q1 TTM) - 22.02% 15.64% 27.35%
Income from Cont. Ops. 5 Year Avg. Change - 10.22% 1.76% 1.25%

MRNA Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - 50.31% 50.94% 136.47%
Q / Q Net Income Growth (Q1 MRQ) - - 427.46% 60.66%
Y / Y Net Income Change (Q1 TTM) - -31.3% -26.89% -1.43%
Seq. Net Income Change (Q1 TTM) - 21.99% 16.31% 26.38%
Net Income 5 Year Avg. Growth - 12.23% 2.2% 1.63%

MRNA's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - 443.9% 50.67% 147.04%
Seq. EPS from Cont. Ops. Change (Q1 MRQ) - - 351.39% 58.7%
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) - - - 33.37%
EPS from Cont. Ops. 5 Year Avg. Growth - 22.16% 1.76% 1.25%



MRNA EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - 443.97% 50.94% 1.25%
Q / Q EPS Net Growth (Q1 MRQ) - - 427.46% 60.66%
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - -27.91%
Seq. EPS Net Change (for 12 months ending Q1 TTM) - - - 31.03%
EPS Net 5 Year Avg. Change - 12.23% 2.2% 1.63%
Expected EPS Growth (Y/Y) - - 123.59% 14.14%



Adhera Therapeutics Inc reported bottom-line of $ -0.12 in the first quarter, compare to $ -0.35 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 443.97%, while Healthcare sector increased by 50.94%, and overall market improved by 136.47%.

Company's sequential EPS growth rate was impressive 239.38% from the forth quarter. Average yearly income per share growth for Adhera Therapeutics Inc is 311.61%, while S & P 500's average annual income per share growth is 1.63% over the five years, including only Businesses with the first quarter 2021 earnings results.

MRNA Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 50.92% 56.71% 152.77%
Seq. Free Cash Flow Change (Q1 MRQ) - -43.24% -25.27% -40%
Y / Y Free Cash Flow Change (Q1 TTM) - 23.96% 23.64% -12.59%
Seq. Free Cash Flow Change (Q1 TTM) 5.24% 7.32% 7.78% 8.67%
Free Cash Flow 5 Year Avg. Change - 16.89% 13.24% 18.4%

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) 1707.58% - - -77.18%
Seq. Net Cash Flow Change (Q1 MRQ) 17.95% - - -8.29%
Y / Y Net Cash Flow Change (Q1 TTM) 3413.15% -18.92% -88.07% 12.26%
Seq. Net Cash Flow Change (Q1 TTM) - -26.98% -55.66% -43.42%
Net Cash Flow 5 Year Avg. Change - 58.63% 38.8% 124.06%

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 462.43% 8.25% 8.54% 2.91%
Seq. Capital Expenditures Change (Q1 MRQ) 50.21% -38.36% -27.21% -23.12%
Y / Y Capital Expenditures Change (Q1 TTM) 1448.89% 18.2% 6.08% -10.35%
Seq. Capital Expenditures Change (Q1 TTM) 42.67% 2.16% 2.2% 0.32%
Capital Expenditures 5 Year Avg. Change - 486.82% 273.33% 85.86%

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HUN's Profile

Stock Price

HUN's Financials

Business Description

Fundamentals

Charts & Quotes

HUN's News

Suppliers

HUN's Competitors

Customers & Markets

Economic Indicators

HUN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071